← Back to Search

Other

Technology-Driven Intervention for Cognitive Impairment (CI Wizard Trial)

N/A
Recruiting
Research Sponsored by HealthPartners Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 months post index visit
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to help early detect cognitive impairment with machine learning & clinical decision support tools, helping patients & caregivers with difficult decisions & improved quality of life.

Who is the study for?
This trial is for people aged 65 or older who visit a participating primary care clinic, have no prior diagnosis of cognitive impairment (CI), and show signs of CI based on specific tests. They must not have had chemotherapy for advanced cancer in the last year, be in hospice or palliative care.
What is being tested?
The study is testing a new system called CI-CDS that uses machine learning to help doctors spot early signs of dementia. It's integrated into electronic health records and aims to improve detection and management of cognitive issues.
What are the potential side effects?
Since this intervention involves technology rather than medication, traditional side effects are not applicable. However, there may be privacy concerns or potential stress related to increased monitoring.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 months post index visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 24 months post index visit for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
CI Diagnosis
Secondary study objectives
Clinician Confidence
Healthcare Utilization Costs

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CI-CDSExperimental Treatment1 Intervention
In clinics randomized to the CI-CDS, the providers will be given the option to use the CI-CDS tool during eligible patient encounters.
Group II: Usual Care (UC)Active Control1 Intervention
In clinics randomized to UC, patients will receive usual care at their primary care visits over the accrual period (no intervention will be given).

Find a Location

Who is running the clinical trial?

HealthPartners InstituteLead Sponsor
194 Previous Clinical Trials
3,718,406 Total Patients Enrolled
8 Trials studying Dementia
3,482 Patients Enrolled for Dementia
National Institute on Aging (NIA)NIH
1,803 Previous Clinical Trials
28,191,510 Total Patients Enrolled
296 Trials studying Dementia
23,632,539 Patients Enrolled for Dementia
OCHIN, Inc.OTHER
22 Previous Clinical Trials
8,722,124 Total Patients Enrolled

Media Library

CI-CDS (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05723523 — N/A
Dementia Research Study Groups: CI-CDS, Usual Care (UC)
Dementia Clinical Trial 2023: CI-CDS Highlights & Side Effects. Trial Name: NCT05723523 — N/A
CI-CDS (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05723523 — N/A
~1000 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top